Trademark Details For BINTRAPDA (Serial Number 79213442)

  •  Home
  •  Print
BINTRAPDA
  • Rank
    Global Trademark Influence Ranking
    4947
0
0
0
0
Serial Number  United States - USPTO 79213442
Registration Number 5362196
Mark
BINTRAPDA
Filing Date Jun-14-2017
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameWilliam C. Wright
AddressEpstein Drangel LLP 60 East 42nd Street, Suite 2520 New York NY 10165

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-26-2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED   REM3E
May-19-2018FINAL DECISION TRANSACTION PROCESSED BY IB   FINVP
Apr-06-2018FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Apr-06-2018FINAL DISPOSITION PROCESSED   FIMPP
Mar-26-2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB   FICRP
Dec-26-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Oct-10-2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Oct-10-2017PUBLISHED FOR OPPOSITION   PUBOA
Sep-20-2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Sep-08-2017REFUSAL PROCESSED BY IB   RFNTP
Aug-25-2017TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Aug-28-2017APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Aug-25-2017TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Aug-25-2017CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Aug-25-2017TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Aug-23-2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB   RFCSP
Aug-23-2017REFUSAL PROCESSED BY MPU   RFRRP
Aug-20-2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW   RFCRE
Aug-19-2017
NON-FINAL ACTION WRITTEN
  
CNRTR
Aug-18-2017ASSIGNED TO EXAMINER   DOCKD
Aug-11-2017APPLICATION FILING RECEIPT MAILED   MAFRO
Aug-07-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM   NWOSI
Aug-04-2017LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Aug-03-2017SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM